Specialised pro-resolving lipid mediators

• 08/02/2017

Acute inflammatory response due to injury or infection is a self-limiting process. Initially, pro-inflammatory lipid mediators derived from the omega-6 fatty acid (FA) arachidonic acid (AA), prostaglandins and leukotrienes play an...

Read more

n-3 PUFAs favour immunity and lessen inflammation in patients undergoing surgery for GI cancer

• 07/05/2017

Surgical resection is the principal treatment in early stages of gastro-intestinal (GI) cancer, but involves the risk of developing several complications, including malnutrition, tumour-induced immunosuppression, surgical stress and...

Read more

Supplementation with omega-3 fatty acids in cardiovascular prevention

• expertomega3
• 06/08/2017

In 2002, the American Heart Foundation (AHA) published a scientific report entitled ‘Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease’. At the time, the evidence from two large randomised, controlled studies had...

Read more

The therapeutic potential of omega-3 in type 1 diabetes

• expertomega3
• 05/29/2017

Type 1 diabetes is a polygenic, autoimmune disease in which a subclass of T cells is involved in autoimmune attacks that cause the destruction of beta pancreatic cells. The treatment for type 1 diabetes involves daily lifelong injections...

Read more